Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Increasing numbers of cancer survivors at high risk for cardiovascular disease

American Cancer Society (ACS) research estimates there are more than 18 million adult survivors of cancer in the United States, and that number is expected to climb to more than 22 million by 2030.

15 Feb 2023

Three new language versions of the 'Together by St. Jude' online resource launched

St. Jude Children's Research Hospital today announced the launch of three new language versions of the Together by St. Jude online resource, a free source of information and education for families facing childhood and adolescent cancer.

15 Feb 2023

Novel predictive index for gastric cancer prognosis

A new research paper was published in Oncotarget's Volume 14 on January 31, 2023, entitled, "Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer."

15 Feb 2023

Integrating AI with infrared imaging to improve colon cancer diagnosis

Artificial intelligence and infrared imaging automatically classify tumors and are faster than previous methods.

14 Feb 2023

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Ipsen (Euronext: IPN; ADR: IPSEY) today announced three-year minimum, 44-month median, follow-up results from the Phase III CheckMate -9ER trial showing that Cabometyx® (cabozantinib) in combination with nivolumab provides survival and response rate benefits after three-years in the first-line treatment of advanced renal cell carcinoma (aRCC), compared to sunitinib.

From Ipsen 14 Feb 2023

Complete genomics drops genome sequencing price to sub $100 at AGBT General Meetin

Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. (“MGI”), today launched new revolutionary products and prices at Advances in Genome Biology and Technology (AGBT) General Meeting.

From MGI 14 Feb 2023

Mark Cuban's cost-plus drug pricing model offers significant savings to patients

A new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs, according to a study published in the Journal of Urology.

10 Feb 2023

Morristown Medical Center reaches significant milestone of performing over 4,000 TAVR

Morristown Medical Center's Gagnon Cardiovascular Institute's structural heart program reached a significant milestone of performing over 4,000 transcatheter aortic valve replacement (TAVR) procedures with well over 650 in 2022 alone.

10 Feb 2023

Socioeconomic deprivation linked with increased late mortality in childhood cancer survivors

St. Jude Children's Research Hospital scientists have found that socioeconomic deprivation, the presence of treatable chronic health conditions and frailty are independently associated with increased late mortality in childhood cancer survivors.

10 Feb 2023

Complete Genomics drops genome sequencing price to sub $100 at AGBT general meeting

From Complete Genomics 9 Feb 2023

Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meeting

From Complete Genomics 9 Feb 2023

Four teams supported by SU2C focus on increasing diversity in early phase cancer clinical trials

Stand Up To Cancer today announced four teams focused on increasing diversity in early phase cancer clinical trials.

8 Feb 2023

Expert work group examines and redefines “clinical meaningfulness” in Alzheimer’s

As the Alzheimer's disease scientific community, patients, and families seek to understand the results of clinical trials of new Alzheimer's treatments, the Alzheimer's Association convened an expert work group to discuss an important and timely issue: the "clinical meaningfulness" of results from these studies.

7 Feb 2023

UC researcher aims to develop better treatments for KRAS-mutated pancreatic cancer

Pancreatic cancer diagnoses are increasing more rapidly than any other cancer type while remaining one of the most deadly cancers.

7 Feb 2023

Liver surgery may be safer in high-volume hospitals

A new paper in the British Journal of Surgery, published by Oxford University Press, finds that patients undergoing liver surgery fare better in higher-volume hospitals; their mortality rates are lower.

7 Feb 2023

Study reveals mechanism of a previously unexplained type of cell death

A study from researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Cell Biology, details a previously unexplained type of cell death called disulfidptosis that could open the door for novel cancer therapeutic strategies.

6 Feb 2023

New type of immunotherapy effective in mice with ovarian cancer

CAR T-cell therapy, a certain kind of cancer treatment in which the immune system's T cells are programmed to attack tumor cells, is effective in mice with ovarian cancer, according to a study published in The Journal for ImmunoTherapy of Cancer.

6 Feb 2023

What is the effectiveness of different exercise modalities in reducing cancer-related fatigue in cancer patients undergoing chemotherapy?

Researchers examined the effect of exercise modalities on cancer-related fatigue.

6 Feb 2023

Rural areas in the U.S. have significantly less access to telehealth and cancer care services

Researchers analyze telehealth provisions and oncological services available in hospitals throughout the United States

5 Feb 2023

MD Anderson collaborates with the Republic of Indonesia to expand its global oncology efforts

The University of Texas MD Anderson Cancer Center today announced the expansion of its global oncology efforts through a new agreement with the Ministry of Health of the Republic of Indonesia.

3 Feb 2023

Oncology News and Research

Further Reading

Increasing numbers of cancer survivors at high risk for cardiovascular disease

Three new language versions of the 'Together by St. Jude' online resource launched

Novel predictive index for gastric cancer prognosis

Integrating AI with infrared imaging to improve colon cancer diagnosis

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Complete genomics drops genome sequencing price to sub $100 at AGBT General Meetin

Mark Cuban's cost-plus drug pricing model offers significant savings to patients

Morristown Medical Center reaches significant milestone of performing over 4,000 TAVR

Socioeconomic deprivation linked with increased late mortality in childhood cancer survivors

Complete Genomics drops genome sequencing price to sub $100 at AGBT general meeting

Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meeting

Four teams supported by SU2C focus on increasing diversity in early phase cancer clinical trials

Expert work group examines and redefines “clinical meaningfulness” in Alzheimer’s

UC researcher aims to develop better treatments for KRAS-mutated pancreatic cancer

Liver surgery may be safer in high-volume hospitals

Study reveals mechanism of a previously unexplained type of cell death

New type of immunotherapy effective in mice with ovarian cancer

What is the effectiveness of different exercise modalities in reducing cancer-related fatigue in cancer patients undergoing chemotherapy?

Rural areas in the U.S. have significantly less access to telehealth and cancer care services

MD Anderson collaborates with the Republic of Indonesia to expand its global oncology efforts

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News